182 related articles for article (PubMed ID: 2563989)
1. Sulfasalazine therapy in inflammatory bowel disease.
Das KM
Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
[TBL] [Abstract][Full Text] [Related]
2. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
3. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
Allgayer H; Kruis W
Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
[No Abstract] [Full Text] [Related]
4. The use of sulfasalazine in the treatment of inflammatory bowel disease.
Spector R
J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
[No Abstract] [Full Text] [Related]
5. [Progress in inflammatory diseases of the colon (author's transl)].
Egger G
Ther Umsch; 1974 Nov; 31(11):804-9. PubMed ID: 4154520
[No Abstract] [Full Text] [Related]
6. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases].
Ewe K
Verh Dtsch Ges Inn Med; 1988; 94():178-84. PubMed ID: 2905098
[No Abstract] [Full Text] [Related]
7. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
Dölle W; Daiss W
Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099
[No Abstract] [Full Text] [Related]
8. Sulphasalazine in inflammatory bowel disease: recent advances.
Cooper BT
N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
[No Abstract] [Full Text] [Related]
9. [Drug information. Pentasa--new Danish drug].
Dahlerup J
Sygeplejersken; 1988 Jul; 88(28):16. PubMed ID: 2902698
[No Abstract] [Full Text] [Related]
10. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
Korelitz BI
Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
[No Abstract] [Full Text] [Related]
11. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
Lendrum R; Walker JG; West B; Hill MJ
Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
[No Abstract] [Full Text] [Related]
12. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
Faintuch J; Mott CB; Machado MC
Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine and new analogues.
Friedman G
Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
[No Abstract] [Full Text] [Related]
14. Inflammatory bowel disease. Part II.
Hansen R
Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
[No Abstract] [Full Text] [Related]
15. [Drug treatment of chronic inflammatory diseases of the intestine].
Modigliani R
Schweiz Med Wochenschr; 1988 May; 118(20):737. PubMed ID: 2898809
[No Abstract] [Full Text] [Related]
16. Pharmacotherapy of inflammatory bowel disease.
Gardner RC
J Maine Med Assoc; 1976 Jul; 67(7):206-14. PubMed ID: 9461
[No Abstract] [Full Text] [Related]
17. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
18. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
20. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Schölmerich J
Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
